Qualigen Therapeutics Announces Partnership with Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies for QN-302
July 6, 2022
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
June 23, 2022
Related Post
-
-
Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO
June 30, 2022
-
Todos Medical Announces Positive Biomarker Data from Phase 2 Trial of Tollovir in Hospitalized COVID-19 Patients
June 30, 2022
-
Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley
June 28, 2022